Valeant Initiates Recall of Nifedipine
Valeant Pharmaceuticals is recalling more than 93,000 bottles of nifedipine extended-release 90 mg tablets throughout the U.S. because they dissolve too quickly.
The drugs were manufactured for Teva Pharmaceuticals at Valeant’s Steinbach, Manitoba, Canada, manufacturing plant, according to an FDA enforcement report.
In all, 10 lots of 100-tablet bottles are affected. The Canadian company’s U.S. arm in Bridgewater, N.J., initiated the recall on April 17 after alerting customers by letter.
Nifedipine is a calcium channel blocker used to treat high blood pressure and angina.
Read the enforcement at www.fdanews.com/06-23-15-ValeantRecall.pdf. — Kellen Owings